Strides Pharma Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The pharma stock is a part of the S&P BSE Smallcap index. It saw an uptrend, rising from Rs 393 as of June 9, 2023, to Rs 901 recorded on June 10, 2024. It has, however, undergone mild consolidation of approximately 100 points since April on the daily chart. The stock is in recovery mode with chances of momentum to continue are moderate. Short-term traders can look to accumulate the stock on dips.

Q4 results on May 22: Petronet LNG, New India Assurance, Metro Brands, Gland Pharma, Sundram Fasteners, Minda Corporation, Gujarat Pipavav Port, HEG, Star Cement, and Indigo Paints, are also among the 32 companies that will announce their Q4 earnings today.

Total expenses in the fourth quarter were higher at Rs 984.21 crore as compared to Rs 972.26 crore.

Strides Pharma Science Ltd reported a consolidated net profit of Rs 10.44 crore for Q4 ending March 2024, reversing a net loss of Rs 13.79 crore a year ago. The company also announced significant top management changes and achieved its highest-ever annual revenue, driven by growth in the US market.

Strides Pharma Science Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 10,840.35 million...